Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeEXECUTIVESFormer U.S. Congressman Erik Paulsen Joins Cardiovascular Systems Board of Directors

Former U.S. Congressman Erik Paulsen Joins Cardiovascular Systems Board of Directors

Cardiovascular Systems, Inc. announced the addition of independent board member Erik Paulsen. He replaces director Scott Bartos, who is retiring from the board after seven years of service. The CSI board continues to have seven directors, six of whom are independent.

From 2009 to 2019, Paulsen represented Minnesota’s Third Congressional District in the United States House of Representatives. During his tenure, Paulsen was a leading member on the House Ways and Means Committee, the House’s tax-writing body with broad jurisdiction over healthcare, economic and trade policy. He also served as Chairman of Congress’ Joint Economic Committee, a unique House-Senate panel tasked with working alongside the President’s Council of Economic Advisors and the Federal Reserve Board to identify and address macroeconomic trends. Paulsen was co-chair of the bipartisan House Medical Technology Caucus, as well. Prior to his service in Congress, Paulsen was a member of the Minnesota State Legislature, where he served as House Majority Leader. Paulsen has over 16 years of business experience, including working as a business analyst at Target Corporation.

“During his time as a member of the United States House of Representatives, Erik was a strong advocate for the medical technology industry, the life-saving technologies it provides to patients and the hundreds of thousands of jobs it supports,” said Scott Ward, CSI Chairman, President and Chief Executive Officer. “His leadership and experience in government affairs will be invaluable as CSI seeks to expand the number of patients it serves.”

Said Ward, “We thank Scott Bartos for his many contributions to CSI throughout the past seven years. During his tenure, over 400,000 patients benefitted from orbital atherectomy. Scott’s counsel helped shape CSI’s strategy as we transform this company from a single technology, single geography company to an innovative leader with worldwide reach.”

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy